e-learning
resources
Barcelona 2013
Saturday, 07.09.2013
PG19 Obstructive sleep-disordered breathing throughout childhood: diagnosis, associated morbidity and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An overview of morbidity associated with obstructive sleep-disordered breathing and indications for treatment
A. Kaditis (Piraeus, Greece)
Source:
Annual Congress 2013 –PG19 Obstructive sleep-disordered breathing throughout childhood: diagnosis, associated morbidity and treatment
Session:
PG19 Obstructive sleep-disordered breathing throughout childhood: diagnosis, associated morbidity and treatment
Session type:
Postgraduate Course
Number:
52
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kaditis (Piraeus, Greece). An overview of morbidity associated with obstructive sleep-disordered breathing and indications for treatment. Annual Congress 2013 –PG19 Obstructive sleep-disordered breathing throughout childhood: diagnosis, associated morbidity and treatment
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: respiratory care for newborns in resource-limited settings
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
What are the treatment options for obstructive sleep-disordered breathing in childhood?
Source: Annual Congress 2013 –PG19 Obstructive sleep-disordered breathing throughout childhood: diagnosis, associated morbidity and treatment
Year: 2013
Treatment for obstructive sleep-disordered breathing improves cardiovascular outcomes
Source: Annual Congress 2013 –PG19 Obstructive sleep-disordered breathing throughout childhood: diagnosis, associated morbidity and treatment
Year: 2013
Preoperative parameters predicting outcome of adenotonsillectomy for obstructive sleep-disordered breathing in children
Source: Eur Respir J 2007; 30: Suppl. 51, 470s
Year: 2007
Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patients
Source: ERJ Open Res, 6 (2) 00101-2019; 10.1183/23120541.00101-2019
Year: 2020
Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002
Cardiovascular morbidity and obstructive sleep apnoea in children
Source: Annual Congress 2009 - Current developments in sleep-disordered breathing in children
Year: 2009
Low prevalence of obstructive sleep apnoea in paediatric severe therapy resistant asthma
Source: International Congress 2019 – Asthma education: lifestyle and adolescence
Year: 2019
Perioperative screening for obstructive sleep apnoea and treatment outcomes: where are the data?
Source: Eur Respir J 2016; 48: 21-22
Year: 2016
Severity of sleep-disordered breathing is an independent predictor of metabolic dysfunction in a population with obstructive sleep apnoea
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Source: Eur Respir J 2010; 35: 132-137
Year: 2010
Predicting outcome of nasal surgery in patients with obstructive sleep apnoea
Source: Eur Respir J 2008; 32: 246
Year: 2008
Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure
Source: Eur Respir J 2004; 24: 443-448
Year: 2004
Ventilatory management in COPD-associated obstructive sleep apnea syndrome
Source: International Congress 2015 – Novelties in noninvasive ventilation
Year: 2015
Cardiovascular morbidity in obstructive sleep apnoea
Source: Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts
Year: 2009
Morbidity and mortality of sleep-disordered breathing: obstructive sleep apnoea and car crash
Source: Breathe 2009; 6: 115-119
Year: 2009
Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Source: Guidelines 2013
Year: 2013
Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease.
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Economic arguments for the immediate management of moderate-to-severe obstructive sleep apnoea syndrome
Source: Eur Respir J 2004; 23: 53-60
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept